Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2021-02-26

First oral treatment for spinal muscular atrophy (SMA) recommended for approval

View source ↗

Summary

The European Medicines Agency recommends approval of the first oral treatment for spinal muscular atrophy, marking a significant milestone in SMA management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oral SMA treatment